3D. HIV&AIDS Invited Speaker Session: Discovery & translational science: HIV Cure Session 1 - Antibody mediated approaches and ATI
Tracks
| Monday, September 14, 2026 |
| 2:00 PM - 3:30 PM |
| Element |
Speaker
Dr Alice Gage-Brown
Basic Physician Trainee
The Royal Melbourne Hospital
Acceptability, motivations and attitudes towards analytical treatment interruptions in HIV cure trials in people living with HIV and their healthcare providers in Australia
2:15 PM - 2:27 PMBiography
Dr Alice Gage-Brown is a trainee physician at The Royal Melbourne Hospital in Melbourne, Australia. She graduated from The University of Melbourne with a Bachelor of Science (Hons) and Doctor of Medicine. Alice’s current research focusses on the social and ethical aspects of HIV cure.
Prof James McMahon
ID Physician
Alfred Health
Low dose Nivolumab in Adults with HIV on Antiretroviral therapy: The NIVO-LD Trial
2:27 PM - 2:39 PMBiography
Professor James McMahon is Head of the Infectious Diseases Clinical Research Unit at the Alfred Hospital, Melbourne and an ID physician at the Alfred, and Monash Medical Centre. He is the current President of ASHM and His research interests include clinical trials for HIV Cure and antiretroviral therapy.
Dr Brianna Jesaveluk
Postdoctoral Researcher
Burnet Institute
Generating glycoengineered broadly-neutralising antibodies to enhance NK cell-mediated elimination of the HIV reservoir
2:39 PM - 2:51 PMBiography
Dr. Brianna Jesaveluk is a postdoctoral researcher in the Life Sciences Discipline at the Burnet Institute, where she was worked since 2018. She is a member of the infection, inflammation and innate immunity working group, with an interest in discovery research for HIV cure immunotherapy approaches.
Dr Gabriel Duette
Senior Research Fellow
The Westmead Institute for Medical Research
Enhanced CD8 T-cell responses following consecutive analytical treatment interruptions are associated with delayed HIV rebound
2:51 PM - 3:03 PMBiography
Gabriel Duette is a Research Fellow at the University of Sydney and Westmead Institute for Medical Research. His research focuses on HIV persistence and immune control, with the goal of developing curative strategies. He combines molecular virology and immunology to study the HIV reservoir and develop CD8 T cell–based therapies.
Dr Jennifer Simpson
Post-doc
WIMR
UTILISING MULTI-OMICS ANALYSIS TO CHARACTERISE HIV PERSISTENCE AT THE SITE OF HIV AND TUBERCULOSIS COINFECTION
3:03 PM - 3:15 PMBiography
Jennifer Simpson is a post-doctoral researcher at WIMR in Sydney, Australia. She completed her PhD at the University of Queensland before completing a post-doc at the National Institutes of Health in the USA. Her current work involves studying the phenotype and TCR repertoire of CD8 T-cells in HIV infection.
Ms Baani Bagga
PhD Candidate
WIMR & University of Sydney
A novel strategy to eradicate HIV using CD8 CAR T cells
3:15 PM - 3:27 PMBiography
Baani Bagga is a PhD candidate at the Westmead Institute for Medical Research (WIMR) and the University of Sydney. Their research focuses on developing novel immunotherapeutic strategies to eradicate HIV, particularly using CD8 CAR T cells to target and eliminate persistent viral reservoirs.
HIV&AIDS Conference
3D. Questions & Discussion
3:27 PM - 3:30 PMBiography
Session Chair
Morgane Brunton-O'Sullivan
Postdoctoral Researcher
Burnet Institute
Najla Nasr
Head - The HIV Immunotherapeutic Lab
Westmead Institute For Medical Research, University of Sydney